Pfizer: Nonalcoholic Steatohepatitis (NASH) – LOI

Proposals in basic, clinical and translational sciences. The research proposals with innovative and the potential of high impact in advancing the learning about NASH will be encouraged.

The followings are the main areas of priority with high unmet needs:

• Biopsy-confirmed NASH prevalence, clinical outcomes, and healthcare utilization
• Innovations in the use of non-invasive tools in the care of patients with NASH

• Understanding genetic drivers of NASH and identification of fast progressors

Funding: up to $140,000.

https://cdn.pfizer.com/pfizercom/2022-09/GMG_20222023-IM-G_NASHASPIRE.pdf?7hII28k3lQwFOBfORRMClofo17PDqKf

https://www.pfizer.com/about/programs-policies/grants/investigator-sponsored-research